We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Five Shares to Watch 2021 – half year update

We take a look at how our five shares to watch for 2021 have performed so far this year: CVS Group, Diageo, Facebook, Ibstock and Tesco.

Important notes

This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.

This article is more than 6 months old

It was correct at the time of publishing. Our views and any references to tax, investment and pension rules may have changed since then.

While there might still be some challenges ahead for the rest of 2021, it seems the light at the end of the tunnel is getting ever brighter. And with the much-delayed reopening of the UK economy now imminent, the market has had an unsurprisingly strong run.

As of 1 July, the UK stock market has delivered a total return of 11.3% this year. But we’re pleased to say the five shares have on average done better – with an average return of 22.9%. That reflects very good results from Diageo, Facebook and CVS Group, with a slightly weaker performance from Ibstock and negative returns from Tesco.

This article isn’t personal advice. Investments can fall as well as rise in value, so you could get back less than you invest. If you’re not sure if an investment is right for you, ask for advice. Past performance isn’t a guide to future returns.

Investing in individual companies isn’t right for everyone. Our five shares to watch are for people who understand the increased risks of investing in individual shares. If the company fails, you risk losing your whole investment. You should make sure you understand the companies you’re investing in, their specific risks, and make sure any shares you own are held as part of a diversified portfolio.

To get more comment and research on the companies listed here sent straight to your inbox, sign up to research updates.

CVS Group

We’ve only had one brief trading update from veterinary group CVS since our first quarter update.

Management reported a steady increase in customer demand. Relaxed coronavirus restrictions mean the group has been able to offer its full range of services since the end of March. As a result the board expected revenue and underlying cash profits to be ahead of previous expectations.

The group also reported a single small bolt-on acquisition in the quarter, continuing its practice of growing through acquisition where appropriate.

Perhaps more important to CVS’s long-term health is the news that between March 2020 and May 2021 almost 3.2m UK households bought a pet – according to data from the Pet Food Manufacturers Association. That takes the total number of pet owning households to 17m, and all of those households will be paying veterinary bills for years to come.

We should flag that these very strong results have been reflected in the CVS share price, though. The shares now trade on a prospective price-to-earnings ratio of 33.3 times earnings, compared to 25.8 at the start of the year. With analysts expecting average revenue growth of just 9.8% between 2020 and 2023, that valuation could be seen as pretty full.

A common valuation measure that divides the share price by profits per share, so will rise if prices increase or expected profits decrease.

Stands for ‘Price to Earnings Ratio’. Ratios should not be looked at in isolation.

See the CVS share price, charts and our latest view

Sign up to receive CVS research direct to your inbox

Diageo

Back in May Diageo updated full year guidance – with organic operating profits expected to be up 14%, slightly better than sales growth. That reflects strong sales growth in North America, with signs of recovery elsewhere too. Given the ongoing disruption to pubs, bars and restaurants around the world, we see that as a real achievement.

The board is similarly reassured and has restarted the £4.5bn capital return programme it suspended in April 2020. That’s currently being rolled out through up to £1bn worth of share buybacks, due to complete before the end of the next financial year.

We think the group has scope for further recovery as vaccine programmes progress and more economies reopen over the coming months.

See the Diageo share price, charts and our latest view

Sign up to receive Diageo research direct to your inbox

Facebook

Regulatory challenges and the very strong growth during the pandemic mean Facebook expects revenue growth to slow as the year progresses.

However, exceptional growth recently, including a 48% sales increase in the first quarter of this year, means even modest growth from this base should be seen as a positive. Having seized a larger share of global advertising spend during the pandemic, we expect the group to fare well when marketing teams purse strings are loosened into a reopening economy.

It’s regulatory news that’s likely to dominate the newspapers where Facebook’s concerned though, and there’s some good news on that front – at least from a shareholder perspective.

At the end of June, a US judge rejected two lawsuits in the US calling for the group to be broken up. That’s important because while Facebook and Instagram might be driving the current revenue boom, it’s the potential of WhatsApp and Messenger’s huge untapped audience that makes Facebook particularly appealing.

See the Facebook share price, charts and our latest view

Sign up to receive Facebook research direct to your inbox

Ibstock

A global shortage in construction materials seems to have sidestepped the brick industry. The industry hasn’t benefitted from the surge in prices seen in products like steel, timber and cement.

Nonetheless Ibstock’s AGM trading statement still had the group trading “modestly ahead of expectations”. Good growth in both the new build and repair and maintenance markets meant brick volumes were ahead of external expectations while concrete was broadly in line.

Longer term strength in the housing market seems to have been unshaken by the pandemic. That’s led Ibstock to invest £60m in new capacity for 115m bricks a year. The new factories will contribute around £12m a year to cash profit from 2024 – with the extra volume supporting future growth even if prices remain flat.

See the Ibstock share price, charts and our latest view

Sign up to receive Ibstock research direct to your inbox

Tesco

While the rate of sales growth has slowed since the peak of the pandemic, Tesco’s first quarter results showed some signs of continued progress – with a recovery in wholesaler Booker leading the way. That more than offset specific headwinds in the Central European and Bank businesses.

However, the company showed last year that rising sales aren’t always enough – with operating profits falling 28.3% despite a 7.0% rise in sales. We suspect that lots of the pandemic related costs behind the profit fall will be difficult to roll back quickly. Tesco bank will likely also continue to struggle while key activities, like travel money, remain subdued. That’s disappointing, we had hoped the group would be more flexible.

Over time we still think Tesco is well placed, though. First quarter online sales were up 22.2% year-on-year, and 81.6% on 2019, reflecting huge investments in capacity. We suspect online grocery shopping will remain permanently higher following the pandemic, and this investment should bear fruit over time. We also expect that costs will come down, even if that takes longer than we had first hoped, with the additional sales picked up in the last 12 months converting to profit. Moreover, with a forecast yield of 4.6% over the next 12 months, investors will at least be paid to wait and see if the group can deliver. Remember no dividend is ever guaranteed, and yields aren't a reliable indicator of what you'll get in the future.

See the Tesco share price, charts and our latest view

Sign up to receive Tesco research direct to your inbox

Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Past performance is not a guide to the future. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.


Share insight: our weekly email

Sign up to receive weekly shares content from HL

Please correct the following errors before you continue:

    Existing client? Please log in to your account to automatically fill in the details below.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Loading

    Your postcode ends:

    Not your postcode? Enter your full address.

    Loading

    Hargreaves Lansdown PLC group companies will usually send you further information by post and/or email about our products and services. If you would prefer not to receive this, please do let us know. We will not sell or trade your personal data.


    What did you think of this article?

    Important notes

    This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.

    Editor's choice – our weekly email

    Sign up to receive the week's top investment stories from Hargreaves Lansdown. Including:

    • Latest comment on economies and markets
    • Expert investment research
    • Financial planning tips
    Sign up

    Related articles

    Category: Markets

    Next week on the stock market

    What to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week.

    Aarin Chiekrie

    01 Dec 2023 4 min read

    Category: Funds

    HL Select turns 7 – what we’ve learned and what’s next

    HL Select Fund Manager Steve Clayton looks back on seven years of the HL Select fund range, how it’s performed and what’s next.

    Steve Clayton

    01 Dec 2023 6 min read

    Category: Investing and saving

    Autumn statement – National Insurance tax change plus ways to help cut your tax bill

    The headline grabbing National Insurance cut might look like good news, but the tax burden is still set to be the highest it’s been since the Second World War. Here’s what’s changed and what you can do to reduce your tax bill.

    Helen Morrissey

    30 Nov 2023 4 min read

    Category: Investing and saving

    Investing in healthcare – where are the opportunities?

    The healthcare sector is enormous, absorbing over 10% of the economic output of many developed nations. We take a closer look at the risks and opportunities to watch out for.

    Derren Nathan

    30 Nov 2023 5 min read